EAM Investors, LLC - ONCOCYTE CORP ownership

ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 56 filers reported holding ONCOCYTE CORP in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
EAM Investors, LLC ownership history of ONCOCYTE CORP
ValueSharesWeighting
Q2 2020$462,000
-31.0%
241,769
+42.5%
0.10%
-37.8%
Q1 2019$670,000169,6350.16%
Other shareholders
ONCOCYTE CORP shareholders Q2 2019
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 3,596,680$27,155,0004.50%
Family Management Corp 20,550$155,0000.11%
Artal Group S.A. 150,000$1,133,0000.02%
Destination Wealth Management 29,656$224,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 145,000$1,095,0000.01%
Carroll Financial Associates, Inc. 850$5,0000.00%
Advisor Group, Inc. 112$1,0000.00%
FIFTH THIRD BANCORP 210$2,0000.00%
HUNTINGTON NATIONAL BANK 10$00.00%
AMERICAN INTERNATIONAL GROUP, INC. 2,413$18,0000.00%
View complete list of ONCOCYTE CORP shareholders